Nuveen Asset Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $13.1M | Buy |
681,012
+452,627
| +198% | +$8.68M | ﹤0.01% | 1453 |
|
|
2024
Q3 | $5.2M | Sell |
228,385
-270,018
| -54% | -$6.14M | ﹤0.01% | 1969 |
|
|
2024
Q2 | $6.48M | Sell |
498,403
-834,051
| -63% | -$10.9M | ﹤0.01% | 1817 |
|
|
2024
Q1 | $23.3M | Buy |
1,332,454
+1,098,574
| +470% | +$19.2M | 0.01% | 1083 |
|
|
2023
Q4 | $5.09M | Buy |
233,880
+30,439
| +15% | +$663K | ﹤0.01% | 1969 |
|
|
2023
Q3 | $3.12M | Sell |
203,441
-222,754
| -52% | -$3.42M | ﹤0.01% | 2104 |
|
|
2023
Q2 | $10.1M | Sell |
426,195
-151,432
| -26% | -$3.6M | ﹤0.01% | 1497 |
|
|
2023
Q1 | $14.7M | Buy |
577,627
+256,161
| +80% | +$6.52M | 0.01% | 1238 |
|
|
2022
Q4 | $10.9M | Buy |
321,466
+218,717
| +213% | +$7.43M | ﹤0.01% | 1431 |
|
|
2022
Q3 | $2.05M | Buy |
102,749
+43,834
| +74% | +$874K | ﹤0.01% | 2393 |
|
|
2022
Q2 | $681K | Buy |
+58,915
| New | +$681K | ﹤0.01% | 2939 |
|